Dexmedetomidine

Dexmedetomidine is a medication used to calm people down, often in emergency situations or for sedation. It helps reduce anxiety and blood pressure. It's usually given as an injection.

Brand names:Igalmi, Precedex
Medication

What people taking Dexmedetomidine report

Every report comes from a Lived member, sent anonymously.

NameHow it went

No reports yet

Add what worked for you with the search bar below

About Dexmedetomidine

What It's For

Dexmedetomidine is a sedative: a medicine that calms people and makes them drowsy. In the US it comes in two very different products. Precedex, and generic dexmedetomidine injection, is a hospital medicine given through a vein. It is used to sedate adults who are on a breathing machine in an intensive care unit (ICU), and to keep adults relaxed and comfortable before and during surgery and other procedures, and children from 1 month old during non-invasive procedures (such as scans), without putting them fully to sleep. A 2025 guideline from the Society of Critical Care Medicine suggests it over propofol, another common ICU sedative, for adults who need sedation in the ICU, a conditional suggestion based on limited evidence. Igalmi is a thin film that dissolves under the tongue or inside the cheek. It is approved for adults with schizophrenia or bipolar I or II disorder who are going through an episode of acute agitation, such as intense restlessness, tension or hostility. It offers a way to calm agitation quickly without an injection, and is given in a supervised setting rather than taken at home.

How It Works

Dexmedetomidine activates alpha-2 receptors, sites on nerve cells that act as a brake on the body's stress and alertness system (the sympathetic nervous system). When those receptors are activated, nerve cells release less norepinephrine, a chemical messenger that drives arousal, vigilance and the fight-or-flight response. The result is a calm, drowsy state that resembles natural sleep more than the deep unconsciousness of general anesthesia. Many people can still be woken and answer questions when someone speaks to them, then drift off again. Because the same brake also slows the heart and relaxes blood vessels, lower blood pressure and a slower heart rate are a predictable part of how the drug acts, not just an occasional side effect.

Dosage & Administration

Precedex is given only by clinicians trained in ICU or operating room care. It runs as a continuous drip through an IV line, usually starting with a measured loading dose over about 10 minutes and then a steady infusion controlled by a pump. The team adjusts the rate to reach the level of sedation they want, and watches heart rate, blood pressure, breathing and oxygen levels the whole time. Older adults and people with liver disease often need lower doses. Igalmi is placed under the tongue or between the cheek and gum and left to dissolve; it should not be chewed or swallowed. After a dose, people should not eat or drink for at least 15 minutes if it was under the tongue, or at least an hour if it was in the cheek. The dose depends on how severe the agitation is, with lower doses for adults 65 and older and people with liver problems. If agitation continues, up to two more doses can be given at least two hours apart, but only after a healthcare provider checks blood pressure and heart rate, including when the person stands.

Side Effects

With the IV form, the most common effects are low blood pressure, a slow heart rate and dry mouth. Blood pressure can also rise briefly while the first loading dose goes in. Because the person is continuously monitored, the team usually notices and manages these changes by slowing or stopping the infusion, giving fluids or using other medicines. Serious drops in blood pressure and heart rate, including some deaths, have been reported, which is why it is used only in monitored settings. With Igalmi, sleepiness is the most common effect, along with numbness or tingling in the mouth, dizziness, dry mouth and low blood pressure, especially on standing. After a dose, people are asked to sit or lie down until their vital signs are normal. Feeling dizzy, lightheaded or faint, particularly when getting up, should be reported to staff right away because it raises the risk of falling.

Interactions & Warnings

Dexmedetomidine adds to the effects of other medicines that cause sedation, including anesthetics, opioid pain medicines, benzodiazepines (a group of anti-anxiety and sedative medicines) and sleep medicines. Doses of one or both often need to be lowered. Its effects on blood pressure and heart rate can also add to those of blood pressure medicines and other drugs that slow the heart. Low blood pressure and a slow heart rate tend to be stronger in older adults and in people who are dehydrated or have diabetes, long-standing high blood pressure, advanced heart block (a problem with the electrical signal that coordinates the heartbeat) or a weak heart muscle. Igalmi is generally avoided in people with low blood pressure (including on standing), advanced heart block, a severely weakened heart or a history of fainting. Igalmi can also prolong the QT interval, a measure of how long the heart takes to recharge between beats on an ECG (electrocardiogram). A longer QT interval raises the risk of a dangerous irregular heartbeat, so Igalmi is avoided in people with known QT prolongation, low potassium or magnesium, or other heart rhythm problems, and alongside other medicines that prolong QT. Some antipsychotics and antibiotics fall in that group, so the full medication list matters. After taking Igalmi, people should not drive or operate hazardous machinery for at least eight hours.

What to Expect

Both forms are meant for short-term use. Precedex infusions are approved for up to 24 hours in the ICU. Use beyond that has been linked to tolerance (needing more for the same effect) and, when stopped, withdrawal effects such as nausea, vomiting, agitation and, less often, a fast heart rate and high blood pressure, so the team watches for these in the day or two afterward. People sedated with dexmedetomidine are often easier to rouse and talk with than those on deeper sedatives, and being roused by voice or touch does not by itself mean the sedation is not working. With Igalmi, the trials that led to its approval measured the main benefit two hours after the dose, when agitation scores were lower than with a placebo. Its safety and effectiveness have not been established beyond 24 hours after the first dose, so it treats an episode rather than replacing ongoing treatment for schizophrenia or bipolar disorder. Drowsiness can last several hours, and the care team checks blood pressure and alertness before the person gets up and moves around.

Questions to Ask Your Doctor

  1. 1.Why is dexmedetomidine being used for sedation rather than propofol or a benzodiazepine, and how deeply sedated will I or my family member be?
  2. 2.How will you monitor blood pressure and heart rate, and what will you do if they drop?
  3. 3.If the infusion runs longer than a day, how will you watch for and manage withdrawal when it stops?
  4. 4.Is Igalmi a good option for my agitation episodes, and how does it fit with my regular schizophrenia or bipolar treatment?
  5. 5.Do any of my current medicines, including antipsychotics or heart medicines, raise my risk of QT problems or low blood pressure with Igalmi?

Last reviewed • Oct 2026

Educational content, not medical advice.